Home > Biosciences and
Healthcare
The table below shows some measurement needs for the UK across key
areas. The information is displayed according to where it fits into the
NMS programmes. Click on any section for more information
on that sector.
The given priority application areas were originally agreed at a series
of roadmapping meetings. If you would like details of the prioritisation
process or would like to comment on any aspect of the roadmaps, please complete
the feedback form
Priority
Application Areas |
Knowledge Base |
Cross-cutting
themes / Other |
Engineering and
Flow |
Materials and
Thermal |
Physical |
Ionising
Radiation |
Chemical and
Biological |
Software for
Metrology |
Biomarkers and
Omics |
Sample
preparation and delivery |
|
Measurement of
biomarkers, for example acoustic or optical |
Radioactive
contrast agents for biomarkers |
Specific and
sensitive measurements, stable molecular and cell reference standards,
experimental design, and validation |
Data fitting
credibility and sample group selection |
Integration with
imaging, cross validation, and ISO34 |
Cell and Tissue
Engineering |
|
Structural Integrity
of tissue scaffolds, characterisation of biomaterials, biomimics, molecular
imprinted polymers, and smart polymers |
|
|
Cell / tissue
characterisation and reference standards, nano-surfaces, cell media and
factors, inferential measurement, safety and efficacy |
|
Accredited "not
tested on animals" labelling |
Point of Care
Testing |
|
Humidity and
wetting |
Validation and
calibration of point of care testing, electrochemistry, optical waveguides and
fluorescence |
|
Small sample
size, homogeneity, validation and traceability, "gold standards", robust omics
and surfaces |
|
Usability standards,
and British In Vitro Diagnostics Association (BIVDA) |
Microdevices |
Validation and flow for
microfluidic structures, sample preparation, homogeneity and
dimensional |
Humidity and
wetting |
Electrochemistry,
optical waveguides and fluorescence |
|
Small sample size,
homogeneity, validation and traceability, "gold standards", robust omics and
surfaces |
|
Usability standards,
and BIVDA |
New Biological
Agents
|
|
|
|
|
Stable
molecular and cell reference standards, in-vitro/ in-vivo correlation,
characterisation, disease markers, and nano-probes |
Bio-informatics,
statistical methods, in-silico modelling |
Clinical trials for
personalised medicine, definition of what is an active component |
Bio and Medical
Imaging |
|
Thermal management of
superconductors |
Image data standards,
device calibration, orthogonal methods, magnetic filed intensity, high
temperature super conductors |
Radioactive contrast
agents for bio-artificial imaging and dosimetry |
Targeting probes for
directed imaging, nanoprobes, and quantum fluorescence |
Artificial intelligence
for diagnosis, data fusion, patient centred data capture, and
bio-informatics |
Integration with
omics |